IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Mirador Capital Partners LP

Q1 2022 Holdings

Filed 2022-05-06 | 203 holdings | $23.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Celldex Therapeutics Inc New(CLDX)COM NEW15117B202$3.1M90,04813.1%
Cytokinetics Inc(CYTK)COM NEW23282W605$5.9M159,49825.1%
Abbvie Inc(ABBV)COM00287Y109$8.1M49,80034.5%
PreviousPage 5 of 5